Correction
Open Access
Correction: CDKL3 promotes osteosarcoma progression by activating Akt/PKB
View ORCID ProfileAina He Correspondence email, Lanjing Ma, Yujing Huang, Haijiao Zhang, Wei Duan, Zexu Li, View ORCID ProfileTeng Fei, Junqing Yuan, Hao Wu, Liguo Liu, Yueqing Bai, Wentao Dai, Yonggang Wang, Hongtao Li, Yong Sun, Yaling Wang, Chunyan Wang, View ORCID ProfileTing Yuan, Qingcheng Yang, View ORCID ProfileSonghai Tian, Min Dong, Ren Sheng Correspondence email, View ORCID ProfileDongxi Xiang Correspondence email
Aina He
1Department of Oncology, Shanghai Jiaotong University Affiliated Sixth People’s Hospital, Shanghai, PR China
2Department of Urology, Boston Children’s Hospital, Harvard Medical School, Boston, MA, USA
Lanjing Ma
3College of Life and Health Sciences, Northeastern University, Shenyang, PR China
Yujing Huang
1Department of Oncology, Shanghai Jiaotong University Affiliated Sixth People’s Hospital, Shanghai, PR China
Haijiao Zhang
3College of Life and Health Sciences, Northeastern University, Shenyang, PR China
Wei Duan
4School of Medicine and Centre for Molecular and Medical Research, Deakin University, Waurn Ponds, Australia
Zexu Li
3College of Life and Health Sciences, Northeastern University, Shenyang, PR China
Teng Fei
3College of Life and Health Sciences, Northeastern University, Shenyang, PR China
Junqing Yuan
5Department of Pathology, Shanghai Jiaotong University Affiliated Sixth People’s Hospital, Shanghai, PR China
Hao Wu
6Department of Vascular Biology, Boston Children’s Hospital, Boston, MA, USA
Liguo Liu
7Department of General Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
Yueqing Bai
5Department of Pathology, Shanghai Jiaotong University Affiliated Sixth People’s Hospital, Shanghai, PR China
Wentao Dai
8Shanghai Center for Bioinformation Technology and Shanghai Engineering Research Center of Pharmaceutical Translation, Shanghai Industrial Technology Institute, Shanghai, PR China
Yonggang Wang
1Department of Oncology, Shanghai Jiaotong University Affiliated Sixth People’s Hospital, Shanghai, PR China
Hongtao Li
1Department of Oncology, Shanghai Jiaotong University Affiliated Sixth People’s Hospital, Shanghai, PR China
Yong Sun
1Department of Oncology, Shanghai Jiaotong University Affiliated Sixth People’s Hospital, Shanghai, PR China
Yaling Wang
1Department of Oncology, Shanghai Jiaotong University Affiliated Sixth People’s Hospital, Shanghai, PR China
Chunyan Wang
1Department of Oncology, Shanghai Jiaotong University Affiliated Sixth People’s Hospital, Shanghai, PR China
Ting Yuan
9Department of Orthopedics, Shanghai Jiaotong University Affiliated Sixth People’s Hospital, Shanghai, PR China
Qingcheng Yang
9Department of Orthopedics, Shanghai Jiaotong University Affiliated Sixth People’s Hospital, Shanghai, PR China
Songhai Tian
2Department of Urology, Boston Children’s Hospital, Harvard Medical School, Boston, MA, USA
Min Dong
2Department of Urology, Boston Children’s Hospital, Harvard Medical School, Boston, MA, USA
Ren Sheng
3College of Life and Health Sciences, Northeastern University, Shenyang, PR China
Dongxi Xiang
10Division of Genetics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA, USA
11Department of Medicine, Harvard Medical School, Boston, MA, USA
12Shanghai Research Center of Biliary Tract Disease Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
Published 21 October 2022. DOI: 10.26508/lsa.202201656
Article Figures & Data
Figures
CDKL3 promotes osteosarcoma via Akt/PKB
Aina He, Lanjing Ma, Yujing Huang, Haijiao Zhang, Wei Duan, Zexu Li, Teng Fei, Junqing Yuan, Hao Wu, Liguo Liu, Yueqing Bai, Wentao Dai, Yonggang Wang, Hongtao Li, Yong Sun, Yaling Wang, Chunyan Wang, Ting Yuan, Qingcheng Yang, Songhai Tian, Min Dong, Ren Sheng, Dongxi Xiang
Life Science Alliance Oct 2022, 5 (11) e202201656; DOI: 10.26508/lsa.202201656
CDKL3 promotes osteosarcoma via Akt/PKB
Aina He, Lanjing Ma, Yujing Huang, Haijiao Zhang, Wei Duan, Zexu Li, Teng Fei, Junqing Yuan, Hao Wu, Liguo Liu, Yueqing Bai, Wentao Dai, Yonggang Wang, Hongtao Li, Yong Sun, Yaling Wang, Chunyan Wang, Ting Yuan, Qingcheng Yang, Songhai Tian, Min Dong, Ren Sheng, Dongxi Xiang
Life Science Alliance Oct 2022, 5 (11) e202201656; DOI: 10.26508/lsa.202201656
In this Issue
Volume 5, No. 11
November 2022
Advertisement
Jump to section
Related Articles
- He, A., Ma, L., Huang, Y., Zhang, H., Duan, W., Li, Z., Fei, T., Yuan, J., Wu, H., Liu, L., Bai, Y., Dai, W., Wang, Y., Li, H., Sun, Y., Wang, Y., Wang, C., Yuan, T., Yang, Q., Tian, S., Dong, M., Sheng, R., & Xiang, D. (2020). CDKL3 promotes osteosarcoma progression by activating Akt/PKB. Life Science Alliance, 3(5), e202000648. Accessed October 09, 2024. https://doi.org/10.26508/lsa.202000648.
Cited By...
- No citing articles found.